Showing 18,401 - 18,420 results of 21,342 for search '(( significance p decrease ) OR ( significant decrease decrease ))', query time: 0.55s Refine Results
  1. 18401

    Algorithm flowchart of OFEO. by Wenshun Sheng (21485393)

    Published 2025
    “…</p></div>…”
  2. 18402
  3. 18403

    Improved detection layer. by Wenshun Sheng (21485393)

    Published 2025
    “…</p></div>…”
  4. 18404
  5. 18405

    The matching process of EIOU. by Wenshun Sheng (21485393)

    Published 2025
    “…</p></div>…”
  6. 18406

    Table 1_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Background<p>Hypertensive heart disease (HHD) poses a substantial global public health burden, particularly among older adults. …”
  7. 18407

    Table 4_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Background<p>Hypertensive heart disease (HHD) poses a substantial global public health burden, particularly among older adults. …”
  8. 18408

    Image 1_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.tif by Ning An (618997)

    Published 2025
    “…Background<p>Hypertensive heart disease (HHD) poses a substantial global public health burden, particularly among older adults. …”
  9. 18409

    Table 3_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Background<p>Hypertensive heart disease (HHD) poses a substantial global public health burden, particularly among older adults. …”
  10. 18410

    Table 2_Unveiling the global impact of hypertensive heart disease among individuals aged ≥ 65 years: metabolic risk factors and future projections for 2050.xlsx by Ning An (618997)

    Published 2025
    “…Background<p>Hypertensive heart disease (HHD) poses a substantial global public health burden, particularly among older adults. …”
  11. 18411

    Principal component analysis of soil parameters. by Wasihun Mengiste (22470304)

    Published 2025
    “…In terms of soil depth, the sand fraction, TP, Av. P, TN, CEC, OM, extractable micronutrients like Fe, Mn, Cu, and Zn decreased with increasing soil depth, while the clay content, BD, pH, and exchangeable bases like Ca, Mg, Na, and K were increased with increasing soil depth. …”
  12. 18412

    Supporting data for "DECODING THE NEUROIMMUNE AXIS OF HEAD AND NECK CANCER TO ENHANCE IMMUNOTHERAPEUTIC OUTCOMES" by Ravi Kishan (11263155)

    Published 2025
    “…Through comprehensive profiling, PTHLH, NMB, GAST, APLN, and LYNX1 were identified as key neuropeptides that potentially mediate the neuroimmune axis in HNSCC.</p><p dir="ltr"><b>Chapter 5</b> focuses on PTHLH, the most significantly upregulated neuropeptide in HNSCC, which showed extensive correlations with neuroimmune factors. …”
  13. 18413

    Supplementary Material for: Off-label Use of Mycophenolate Mofetil in Immunoglobulin A Nephropathy: A Systematic Review and Meta-analysis by Feng L. (5056958)

    Published 2024
    “…No significant differences were detected in the incidence of ESRD (RR: 0.87, 95% CI: 0.38 to 2.03), or progression of chronic kidney disease (RR, 1.01; 95%CI, 0.22 to 4.57). …”
  14. 18414

    Supplementary file 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotempor... by Ying Feng (151159)

    Published 2025
    “…The overall disease burden decreased with age, particularly when high BMI exposure was below the 40th percentile (P40). …”
  15. 18415

    Table 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotemporal analysis b... by Ying Feng (151159)

    Published 2025
    “…The overall disease burden decreased with age, particularly when high BMI exposure was below the 40th percentile (P40). …”
  16. 18416

    Presentation1_Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach.PPTX by Ji Zeng (4336561)

    Published 2024
    “…</p>Conclusion<p>BZYQ demonstrates significant efficacy in treating CRF with minimal adverse reactions. …”
  17. 18417

    Supplementary Material for: The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient by Hiraoka A. (4273894)

    Published 2025
    “…Positive rates for AFP (67.8%, 62.1%, 50.8%, respectively) and DCP (84.1%, 80.5%, 72.7%, respectively) were decreased (each P<0.001), while the AFP-L3 rate did not show a significant change (54.4%, 57.7%, 51.9%, respectively P=0.390). …”
  18. 18418

    Supplementary Material for: A Case Report of Intravitreal Aflibercept for Iris Metastasis from Small Cell Lung Carcinoma with Neovascular Glaucoma by figshare admin karger (2628495)

    Published 2025
    “…Although not curative, this therapeutic approach may play a significant role in the symptom management of these patients.…”
  19. 18419

    Uncovering Urinary Proteome Differences in Very Preterm Infants with and without Preterm Brain Injury by Magdalena Zasada (4524901)

    Published 2025
    “…Conversely, fatty acid-binding proteins (FABP1, FABP3, FABP4, FABP7) decreased over time in uninjured infants but increased in those with brain injury, suggesting a role in exacerbating damage. …”
  20. 18420

    Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders by Santosh Kumar Rai (22382996)

    Published 2025
    “…Chronic treatment of MKP10241 in DIO-mice exhibited marked reduction in body weight and feed intake at tested doses, which was associated with decreased blood glucose level, lipid parameters, and body fats. …”